Welcome to Paid Research Studies




  • Conditions:   Alzheimer Disease, Early Onset;   Alzheimer Disease;   Alzheimer Disease, Late Onset;   Dementia, Alzheimer Type;   Logopenic Progressive Aphasia;   Primary Progressive Aphasia;   Visuospatial/Perceptual Abilities;   Posterior Cortical Atrophy;   Executive Dysfunction;   Corticobasal Degeneration;   Ideomotor Apraxia
    Intervention:  
    Sponsors:   University of California, Los Angeles;   National Institute on Aging (NIA);   University of Southern California
    Recruiting - verified May 2017

  • Conditions:   Hearing Loss;   Deafness
    Interventions:   Behavioral: Aural Rehabilitation Group;   Behavioral: Cognitive Training Group
    Sponsor:   Gallaudet University
    Recruiting - verified May 2017

  • Condition:   Respiratory Failure
    Interventions:   Other: Proloquo2Go;   Other: Standard of Care
    Sponsors:   Medical College of Wisconsin;   Marquette University
    Recruiting - verified May 2017

  • Condition:   Frontotemporal Dementia
    Interventions:   Drug: 18F-AV-1451;   Drug: 18F-AV-45
    Sponsor:   Avid Radiopharmaceuticals
    Recruiting - verified May 2017

  • Condition:   Brain Tumor
    Intervention:   Other: Cognitive Surveys
    Sponsor:   Mayo Clinic
    Recruiting - verified March 2017

  • Conditions:   Teach-Back Communication;   Arthritis;   Knee Osteoarthritis;   Knee Arthropathy
    Intervention:   Other: Teach-Back Lesson
    Sponsor:   Duke University
    Recruiting - verified February 2017

  • Condition:   Aphasia
    Interventions:   Behavioral: Language therapy;   Behavioral: Background Music;   Behavioral: Aerobic Exercise
    Sponsor:   New York University School of Medicine
    Recruiting - verified December 2016

  • Condition:   Malignant Neoplasms of Independent (Primary) Multiple Sites
    Interventions:   Behavioral: Questionnaires;   Other: Video Presentation
    Sponsor:   M.D. Anderson Cancer Center
    Recruiting - verified April 2017

  • Condition:   Cognitive Impairment
    Interventions:   Other: Pre-visit patient-family agenda-setting checklist;   Other: Usual care
    Sponsors:   Johns Hopkins Bloomberg School of Public Health;   Johns Hopkins Community Physicians;   MedStar Health
    Recruiting - verified December 2016

  • Conditions:   Corticobasal Degeneration (CBD);   Corticobasal Syndrome (CBS);   Cortical-basal Ganglionic Degeneration (CBGD);   Progressive Supranuclear Palsy (PSP);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   Oligosymptomatic/Variant Progressive Supranuclear Palsy (o/vPSP)
    Intervention:   Other: Observational Study
    Sponsors:   University of California, San Francisco;   National Institutes of Health (NIH);   National Institute on Aging (NIA)
    Recruiting - verified November 2016

  • Conditions:   Severe Life-limiting COPD;   Severe Life-limiting Heart Failure;   Severe Life-limiting Cirrhosis;   Severe Life-limiting Malignancy;   Severe Functional Impairment
    Interventions:   Behavioral: Informed Assent Discussion;   Behavioral: Usual Care with Attention Control
    Sponsors:   University of Vermont;   University of Washington;   Medical University of South Carolina;   University of California, San Francisco
    Recruiting - verified May 2017

  • Conditions:   Posttraumatic Stress Disorder;   Anger
    Intervention:   Behavioral: Connectd mobile application
    Sponsors:   InferLink Corporation;   Duke University;   University of California, Los Angeles
    Recruiting - verified November 2016

  • Condition:   Niemann-Pick Disease, Type C1
    Intervention:   Drug: Hydroxypropyl-beta-cyclodextrin
    Sponsor:   CTD Holdings, Inc.
    Recruiting - verified March 2017

  • Conditions:   Hearing Loss;   Language Development;   Social Behavior
    Interventions:   Behavioral: augmentative and alternative communication technology;   Behavioral: Usual Care
    Sponsor:   Children's Hospital Medical Center, Cincinnati
    Recruiting - verified December 2016

  • Condition:   Aphasia
    Intervention:   Behavioral: Semantic Feature Analysis (SFA)
    Sponsors:   Boston University Charles River Campus;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified April 2017

  • Conditions:   Stuttering, Adult;   Childhood-onset Fluency Disorder;   Speech Disorders;   Language Disorders;   Communication Disorder
    Interventions:   Drug: Ecopipam 50mg;   Drug: Ecopipam 100mg
    Sponsors:   Gerald Maguire, MD;   University of California Riverisde School of Medicine
    Recruiting - verified October 2016

  • Condition:   Stroke
    Interventions:   Device: Anodal or Cathodal tDCS;   Device: Sham;   Behavioral: Computerized naming therapy
    Sponsors:   Johns Hopkins University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified May 2017

  • Condition:   Frontotemporal Dementia (FTD)
    Interventions:   Drug: Lithium Carbonate;   Drug: Placebo
    Sponsors:   Columbia University;   Alzheimer’s Drug Discovery Foundation
    Recruiting - verified April 2017

  • Condition:   Autism Spectrum Disorder
    Interventions:   Drug: Oxytocin and social cognitive skills group;   Behavioral: Facilitated Play Therapy
    Sponsors:   Rush University Medical Center;   University of Illinois at Chicago;   University of Chicago;   Northwestern University;   Eotvos Lorand University
    Recruiting - verified November 2016

  • Condition:   Autism Spectrum Disorder
    Interventions:   Drug: Folinic Acid;   Other: Placebo
    Sponsors:   Emory University;   Arkansas Children's Hospital Research Institute;   Harvard University
    Not yet recruiting - verified September 2016

  • Conditions:   Neuroblastoma;   Sarcoma;   Carcinoma;   Desmoplastic Small Round Cell Tumor;   Retinoblastoma;   Wilms Tumor;   Melanoma;   Germ Cell Tumor;   Hepatoblastoma
    Intervention:  
    Sponsor:   St. Jude Children's Research Hospital
    Recruiting - verified April 2017

  • Condition:   Prostate Cancer
    Interventions:   Behavioral: Patients: Questions to Ask Your Doctor: A Workbook for Patient-Doctor Teams;   Behavioral: Physicians: Educational Module
    Sponsors:   Susan Eggly;   National Cancer Institute (NCI)
    Recruiting - verified September 2016

  • Condition:   Sickle Cell Disease
    Intervention:   Behavioral: SCThrive Intervention for Adolescents with SCD
    Sponsor:   Children's Hospital Medical Center, Cincinnati
    Recruiting - verified July 2016

  • Conditions:   Stroke;   Aphasia
    Intervention:   Device: Transcranial Magnetic Stimulation
    Sponsor:   University of Pennsylvania
    Recruiting - verified August 2016

  • Conditions:   Mechanical Ventilation;   Nonverbal Communication;   Intratracheal Intubation;   Critical Illness
    Interventions:   Device: Brain Computer Interface (BCI) device;   Other: Communication picture board
    Sponsors:   University of Michigan;   Michigan Institute for Clinical and Health Research (MICHR)
    Recruiting - verified March 2017

  • Condition:   Primary Progressive Aphasia
    Intervention:   Drug: F-18 AV 1451
    Sponsor:   Mayo Clinic
    Recruiting - verified March 2017

  • Conditions:   Atypical Alzheimer's Disease;   Logopenic Progressive Aphasia (LPA);   Posterior Cortical Atrophy (PCA)
    Interventions:   Drug: F-18 AV 1451;   Drug: C-11 PiB
    Sponsor:   Mayo Clinic
    Recruiting - verified December 2016

  • Condition:   Attention-Deficit/Hyperactivity Disorder
    Interventions:   Behavioral: Care Manager;   Other: ADHD Portal
    Sponsors:   Children's Hospital of Philadelphia;   Patient-Centered Outcomes Research Institute
    Recruiting - verified September 2016

  • Conditions:   Articulation Disorder;   Dysarthria;   Prelingual Deafness
    Intervention:   Device: Opti-Speech
    Sponsors:   Vulintus, Inc.;   National Institute on Deafness and Other Communication Disorders (NIDCD);   Callier Center for Communication Disorders;   Cleveland Hearing and Speech Center;   Case Western Reserve University
    Recruiting - verified October 2016

  • Condition:   Lung Cancer
    Interventions:   Behavioral: Questionnaire;   Behavioral: Patient Interview;   Behavioral: Audio recordings of clinical consultations
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Hamad Medical Corporation;   University of Arizona;   Weill Medical College of Cornell University
    Recruiting - verified February 2017

  • Condition:   Aphasia
    Intervention:   Behavioral: Word repetition after a time delay.
    Sponsors:   Temple University;   University of Pennsylvania
    Recruiting - verified December 2016

  • Condition:   Aphasia
    Interventions:   Device: Active tDCS plus Speech-Language Therapy;   Device: Sham plus Speech-Language Therapy
    Sponsor:   Johns Hopkins University
    Recruiting - verified March 2017

  • Condition:   Autism Spectrum Disorder
    Intervention:   Behavioral: J-EMT for Toddlers with Autism
    Sponsors:   Vanderbilt University;   Northwestern University
    Recruiting - verified April 2017

  • Conditions:   Apraxias;   Communication Disorders;   Speech Disorders
    Interventions:   Device: EPG Tx;   Behavioral: SPT
    Sponsor:   VA Office of Research and Development
    Recruiting - verified June 2017

  • Condition:   Niemann-Pick Disease, Type C
    Interventions:   Drug: VTS-270;   Drug: Sham Procedure Control
    Sponsor:   Vtesse Inc.
    Recruiting - verified January 2017

  • Conditions:   Autism Spectrum Disorder;   Moderate Language Delay
    Interventions:   Behavioral: Direct Instruction-Language for Learning (DI-LL);   Behavioral: Treatment as Usual
    Sponsor:   Emory University
    Recruiting - verified June 2016

  • Condition:   Diabetes Mellitus
    Interventions:   Behavioral: Pamphlet;   Behavioral: Video
    Sponsor:   VA Office of Research and Development
    Recruiting - verified May 2017

  • Conditions:   Primary Progressive Aphasia;   Alzheimer's Disease;   Frontotemporal Dementia
    Intervention:   Behavioral: Monthly Check-in Session
    Sponsors:   Northwestern University;   Alzheimer's Association;   The Association for Frontotemporal Degeneration
    Recruiting - verified August 2016

  • Conditions:   Breast Carcinoma;   Female Reproductive System Neoplasm;   Genitourinary System Cancer;   Malignant Neoplasm
    Interventions:   Other: Internet-Based Intervention;   Other: Educational Intervention;   Other: Communication Intervention;   Other: Questionnaire Administration;   Other: Quality-of-Life Assessment
    Sponsors:   City of Hope Medical Center;   National Cancer Institute (NCI)
    Recruiting - verified February 2017

  • Condition:   Familial Frontotemporal Dementia
    Intervention:  
    Sponsors:   Mayo Clinic;   National Institute on Aging (NIA);   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting - verified March 2017

  • Conditions:   FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
    Intervention:  
    Sponsors:   University of California, San Francisco;   National Center for Advancing Translational Science (NCATS);   National Institute of Neurological Disorders and Stroke (NINDS);   The Bluefield Project;   Tau Consortium
    Recruiting - verified March 2017

  • Condition:   Chronic Kidney Disease
    Intervention:   Behavioral: advance care planning
    Sponsors:   Baystate Medical Center;   University of New Mexico;   Northeastern University;   Patient-Centered Outcomes Research Institute
    Recruiting - verified July 2016

  • Conditions:   Brain Cancer;   Glioblastoma
    Intervention:   Behavioral: psychometric tests, questionnaires and neurocognitive assessments
    Sponsors:   Memorial Sloan Kettering Cancer Center;   Weill Medical College of Cornell University
    Recruiting - verified January 2017

  • Conditions:   Aphasia;   CVA;   Apraxia of Speech
    Intervention:   Behavioral: Sound Production Treatment (SPT)
    Sponsor:   VA Office of Research and Development
    Recruiting - verified April 2017

  • Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Progressive Muscular Atrophy;   Multisystem Proteinopathy
    Intervention:  
    Sponsors:   University of Miami;   National Institute of Neurological Disorders and Stroke (NINDS);   National Center for Advancing Translational Science (NCATS);   St. Jude Children's Research Hospital;   ALS Association
    Recruiting - verified November 2016

  • Condition:   Major Depressive Disorder
    Interventions:   Behavioral: aTAU + sTVi;   Behavioral: aTAU + Attention Control Videos
    Sponsors:   Butler Hospital;   National Institute of Mental Health (NIMH)
    Not yet recruiting - verified May 2017

  • Condition:   Major Depressive Disorder
    Intervention:   Behavioral: Storytelling Video Intervention (sTVi)
    Sponsors:   Butler Hospital;   National Institute of Mental Health (NIMH)
    Recruiting - verified May 2017

  • Condition:   Autism Spectrum Disorder
    Intervention:   Behavioral: Intervention JEP
    Sponsor:   Vanderbilt University
    Recruiting - verified April 2017

  • Conditions:   Stroke;   Aphasia
    Intervention:   Device: transcranial direct current stimulation
    Sponsor:   Northwell Health
    Recruiting - verified August 2016

  • Conditions:   Adrenoleukodystrophy;   Batten Disease;   Mucopolysaccharidosis II;   Leukodystrophy, Globoid Cell;   Leukodystrophy, Metachromatic;   Neimann Pick Disease;   Pelizaeus-Merzbacher Disease;   Sandhoff Disease;   Tay-Sachs Disease;   Brain Diseases, Metabolic, Inborn
    Intervention:   Biological: DUOC-01
    Sponsors:   Joanne Kurtzberg, MD;   The Marcus Foundation
    Recruiting - verified April 2017

  • Condition:   Aphasia
    Interventions:   Device: transcranial direct current stimulation;   Other: Non-Prime Condition;   Behavioral: Traditional behavioral treatment
    Sponsor:   University of Minnesota - Clinical and Translational Science Institute
    Recruiting - verified April 2017

  • Condition:   Metastatic Colorectal Cancer
    Interventions:   Other: Investigational informed consent for chemotherapy;   Other: Usual, standard-of-care informed consent for chemotherapy
    Sponsors:   Dana-Farber Cancer Institute;   Patient-Centered Outcomes Research Institute;   Alliance for Clinical Trials in Oncology;   National Cancer Institute (NCI)
    Recruiting - verified April 2017

  • Condition:   Stroke and Aphasia
    Intervention:   Behavioral: Communal singing
    Sponsor:   Beth Israel Medical Center
    Recruiting - verified September 2016

  • Conditions:   Language Impairment;   Down Syndrome
    Intervention:   Behavioral: Jasper-EMT with words and AAC
    Sponsors:   Vanderbilt University;   University of California, Los Angeles
    Recruiting - verified April 2017

  • Conditions:   Lysosomal Storage Disorders;   Gaucher Disease;   Fabry Disease;   Pompe Disease;   Niemann-Pick Disease
    Intervention:  
    Sponsor:   O & O Alpan LLC
    Recruiting - verified April 2017

  • Condition:   Healthy, no Evidence of Disease
    Interventions:   Other: IMPACT intervention;   Other: Online education materials;   Other: survey administration
    Sponsors:   Case Comprehensive Cancer Center;   National Cancer Institute (NCI)
    Recruiting - verified September 2016

  • Condition:   Stroke
    Intervention:   Behavioral: Semantic Feature Analysis therapy
    Sponsors:   VA Office of Research and Development;   Portland State University;   University of Washington
    Recruiting - verified February 2017

  • Conditions:   Deep Vein Thrombosis;   Blood Clots
    Intervention:  
    Sponsor:   National Human Genome Research Institute (NHGRI)
    Recruiting - verified May 30, 2017

  • Conditions:   Aphasia;   Stroke
    Intervention:   Behavioral: Speech Production Treatment
    Sponsor:   VA Office of Research and Development
    Recruiting - verified February 2017

  • Conditions:   Ataxia;   Dystonia;   Parkinson's Disease;   Amyotrophic Lateral Sclerosis;   Corticobasal Degeneration;   Multiple System Atrophy;   Alzheimer's Disease;   Lewy Body Dementia;   Parkinson Disease-Dementia;   Dentatorubral-pallidoluysian Atrophy;   Creutzfeldt-Jakob Disease and Fatal Familial Insomnia;   Fragile X-associated Tremor/Ataxia Syndrome;   Krabbe's Disease;   Niemann-Pick Disease, Type C;   Neuronal Ceroid Lipofuscinosis
    Intervention:  
    Sponsor:   National Institute on Aging (NIA)
    Recruiting - verified April 11, 2017

  • Conditions:   Aphasia;   Stroke
    Intervention:   Behavioral: Naming therapy
    Sponsor:   VA Office of Research and Development
    Recruiting - verified February 2017

  • Conditions:   Intellectual Disabilities;   Speech Delay;   Language Disorder
    Intervention:   Behavioral: Pivotal Response Treatment (PRT)
    Sponsor:   Stanford University
    Recruiting - verified February 2017

  • Conditions:   Critically Ill Intensive Care Unit Patients;   Physician-Family Communication in Intensive Care Units;   Surrogate Decision-making for Critically Ill Patients
    Interventions:   Behavioral: Four Supports Intervention;   Behavioral: Educational Control Intervention
    Sponsors:   University of Pittsburgh;   National Institute on Aging (NIA)
    Recruiting - verified October 2016

  • Condition:   Parkinson Disease
    Interventions:   Behavioral: Emotional prosodic treatment;   Behavioral: Standard prosodic treatment
    Sponsor:   VA Office of Research and Development
    Recruiting - verified December 2016

  • Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Lobar Degeneration
    Intervention:  
    Sponsors:   National Institute of Neurological Disorders and Stroke (NINDS);   National Institute on Aging (NIA)
    Recruiting - verified March 16, 2017

  • Condition:   Breast Cancer
    Intervention:   Behavioral: Breast Cancer Screening Decision Aid
    Sponsor:   University of Pennsylvania
    Recruiting - verified August 2016

  • Conditions:   PPA;   Non-fluent Aphasia;   Apraxia of Speech;   Primary Progressive Non-fluent Aphasia;   Primary Progressive Aphasia
    Intervention:   Drug: FDG Fluorodeoxyglucose 18
    Sponsor:   Mayo Clinic
    Recruiting - verified December 2016

  • Condition:   Specific Language Impairment
    Intervention:   Behavioral: Treatment (interactive book reading, dialogic reading, shared book reading)
    Sponsors:   University of Kansas;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified October 2016

  • Conditions:   Rare Disorders;   Undiagnosed Disorders;   Disorders of Unknown Prevalence;   Cornelia De Lange Syndrome;   Prenatal Benign Hypophosphatasia;   Perinatal Lethal Hypophosphatasia;   Odontohypophosphatasia;   Adult Hypophosphatasia;   Childhood-onset Hypophosphatasia;   Infantile Hypophosphatasia;   Hypophosphatasia;   Kabuki Syndrome;   Bohring-Opitz Syndrome;   Narcolepsy Without Cataplexy;   Narcolepsy-cataplexy;   Hypersomnolence Disorder;   Idiopathic Hypersomnia Without Long Sleep Time;   Idiopathic Hypersomnia With Long Sleep Time;   Idiopathic Hypersomnia;   Kleine-Levin Syndrome;   Kawasaki Disease;   Leiomyosarcoma;   Leiomyosarcoma of the Corpus Uteri;   Leiomyosarcoma of the Cervix Uteri;   Leiomyosarcoma of Small Intestine;   Acquired Myasthenia Gravis;   Addison Disease;   Hyperacusis (Hyperacousis);   Juvenile Myasthenia Gravis;   Transient Neonatal Myasthenia Gravis;   Williams Syndrome;   Lyme Disease;   Myasthenia Gravis;   Marinesco Sjogren Syndrome(Marinesco-Sjogren Syndrome);   Isolated Klippel-Feil Syndrome;   Frasier Syndrome;   Denys-Drash Syndrome;   Beckwith-Wiedemann Syndrome;   Emanuel Syndrome;   Isolated Aniridia;   Beckwith-Wiedemann Syndrome Due to Paternal Uniparental Disomy of Chromosome 11;   Beckwith-Wiedemann Syndrome Due to Imprinting Defect of 11p15;   Beckwith-Wiedemann Syndrome Due to 11p15 Translocation/Inversion;   Beckwith-Wiedemann Syndrome Due to 11p15 Microduplication;   Beckwith-Wiedemann Syndrome Due to 11p15 Microdeletion;   Axenfeld-Rieger Syndrome;   Aniridia-intellectual Disability Syndrome;   Aniridia - Renal Agenesis - Psychomotor Retardation;   Aniridia - Ptosis - Intellectual Disability - Familial Obesity;   Aniridia - Cerebellar Ataxia - Intellectual Disability;   Aniridia - Absent Patella;   Aniridia;   Peters Anomaly - Cataract;   Peters Anomaly;   Potocki-Shaffer Syndrome;   Silver-Russell Syndrome Due to Maternal Uniparental Disomy of Chromosome 11;   Silver-Russell Syndrome Due to Imprinting Defect of 11p15;   Silver-Russell Syndrome Due to 11p15 Microduplication;   Syndromic Aniridia;   WAGR Syndrome;   Wolf-Hirschhorn Syndrome;   4p16.3 Microduplication Syndrome;   4p Deletion Syndrome, Non-Wolf-Hirschhorn Syndrome;   Autosomal Recessive Stickler Syndrome;   Stickler Syndrome Type 2;   Stickler Syndrome Type 1;   Stickler Syndrome;   Mucolipidosis Type 4;   X-linked Spinocerebellar Ataxia Type 4;   X-linked Spinocerebellar Ataxia Type 3;   X-linked Intellectual Disability - Ataxia - Apraxia;   X-linked Progressive Cerebellar Ataxia;   X-linked Non Progressive Cerebellar Ataxia;   X-linked Cerebellar Ataxia;   Vitamin B12 Deficiency Ataxia;   Toxic Exposure Ataxia;   Unclassified Autosomal Dominant Spinocerebellar Ataxia;   Thyroid Antibody Ataxia;   Sporadic Adult-onset Ataxia of Unknown Etiology;   Spinocerebellar Ataxia With Oculomotor Anomaly;   Spinocerebellar Ataxia With Epilepsy;   Spinocerebellar Ataxia With Axonal Neuropathy Type 2;   Spinocerebellar Ataxia Type 8;   Spinocerebellar Ataxia Type 7;   Spinocerebellar Ataxia Type 6;   Spinocerebellar Ataxia Type 5;   Spinocerebellar Ataxia Type 4;   Spinocerebellar Ataxia Type 37;   Spinocerebellar Ataxia Type 36;   Spinocerebellar Ataxia Type 35;   Spinocerebellar Ataxia Type 34;   Spinocerebellar Ataxia Type 32;   Spinocerebellar Ataxia Type 31;   Spinocerebellar Ataxia Type 30;   Spinocerebellar Ataxia Type 3;   Spinocerebellar Ataxia Type 29;   Spinocerebellar Ataxia Type 28;   Spinocerebellar Ataxia Type 27;   Spinocerebellar Ataxia Type 26;   Spinocerebellar Ataxia Type 25;   Spinocerebellar Ataxia Type 23;   Spinocerebellar Ataxia Type 22;   Spinocerebellar Ataxia Type 21;   Spinocerebellar Ataxia Type 20;   Spinocerebellar Ataxia Type 2;   Spinocerebellar Ataxia Type 19/22;   Spinocerebellar Ataxia Type 18;   Spinocerebellar Ataxia Type 17;   Spinocerebellar Ataxia Type 16;   Spinocerebellar Ataxia Type 15/16;   Spinocerebellar Ataxia Type 14;   Spinocerebellar Ataxia Type 13;   Spinocerebellar Ataxia Type 12;   Spinocerebellar Ataxia Type 11;   Spinocerebellar Ataxia Type 10;   Spinocerebellar Ataxia Type 1 With Axonal Neuropathy;   Spinocerebellar Ataxia Type 1;   Spinocerebellar Ataxia - Unknown;   Spinocerebellar Ataxia - Dysmorphism;   Non Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Spectrin-associated Autosomal Recessive Cerebellar Ataxia;   Spasticity-ataxia-gait Anomalies Syndrome;   Spastic Ataxia With Congenital Miosis;   Spastic Ataxia - Corneal Dystrophy;   Spastic Ataxia;   Rare Hereditary Ataxia;   Rare Ataxia;   Recessive Mitochondrial Ataxia Syndrome;   Progressive Epilepsy and/or Ataxia With Myoclonus as a Major Feature;   Posterior Column Ataxia - Retinitis Pigmentosa;   Post-Stroke Ataxia;   Post-Head Injury Ataxia;   Post Vaccination Ataxia;   Polyneuropathy - Hearing Loss - Ataxia - Retinitis Pigmentosa - Cataract;   Muscular Atrophy - Ataxia - Retinitis Pigmentosa - Diabetes Mellitus;   Non-progressive Cerebellar Ataxia With Intellectual Disability;   Non-hereditary Degenerative Ataxia;   Paroxysmal Dystonic Choreathetosis With Episodic Ataxia and Spasticity;   Olivopontocerebellar Atrophy - Deafness;   NARP Syndrome;   Myoclonus - Cerebellar Ataxia - Deafness;   Multiple System Atrophy, Parkinsonian Type;   Multiple System Atrophy, Cerebellar Type;   Multiple System Atrophy;   Maternally-inherited Leigh Syndrome;   Machado-Joseph Disease Type 3;   Machado-Joseph Disease Type 2;   Machado-Joseph Disease Type 1;   Lethal Ataxia With Deafness and Optic Atrophy;   Leigh Syndrome;   Leukoencephalopathy With Mild Cerebellar Ataxia and White Matter Edema;   Leukoencephalopathy - Ataxia - Hypodontia - Hypomyelination;   Leigh Syndrome With Nephrotic Syndrome;   Leigh Syndrome With Leukodystrophy;   Leigh Syndrome With Cardiomyopathy;   Late-onset Ataxia With Dementia;   Intellectual Disability-hyperkinetic Movement-truncal Ataxia Syndrome;   Infection or Post Infection Ataxia;   Infantile-onset Autosomal Recessive Nonprogressive Cerebellar Ataxia;   Infantile Onset Spinocerebellar Ataxia;   GAD Ataxia;   Hereditary Episodic Ataxia;   Gliadin/Gluten Ataxia;   Friedreich Ataxia;   Fragile X-associated Tremor/Ataxia Syndrome;   Familial Paroxysmal Ataxia;   Exposure to Medications Ataxia;   Episodic Ataxia With Slurred Speech;   Episodic Ataxia Unknown Type;   Episodic Ataxia Type 7;   Episodic Ataxia Type 6;   Episodic Ataxia Type 5;   Episodic Ataxia Type 4;   Episodic Ataxia Type 3;   Episodic Ataxia Type 1;   Epilepsy and/or Ataxia With Myoclonus as Major Feature;   Early-onset Spastic Ataxia-neuropathy Syndrome;   Early-onset Progressive Neurodegeneration - Blindness - Ataxia - Spasticity;   Early-onset Cerebellar Ataxia With Retained Tendon Reflexes;   Early-onset Ataxia With Dementia;   Childhood-onset Autosomal Recessive Slowly Progressive Spinocerebellar Ataxia;   Dilated Cardiomyopathy With Ataxia;   Cataract - Ataxia - Deafness;   Cerebellar Ataxia, Cayman Type;   Cerebellar Ataxia With Peripheral Neuropathy;   Cerebellar Ataxia - Hypogonadism;   Cerebellar Ataxia - Ectodermal Dysplasia;   Cerebellar Ataxia - Areflexia - Pes Cavus - Optic Atrophy - Sensorineural Hearing Loss;   Brain Tumor Ataxia;   Brachydactyly - Nystagmus - Cerebellar Ataxia;   Benign Paroxysmal Tonic Upgaze of Childhood With Ataxia;   Autosomal Recessive Syndromic Cerebellar Ataxia;   Autosomal Recessive Spastic Ataxia With Leukoencephalopathy;   Autosomal Recessive Spastic Ataxia of Charlevoix-Saguenay;   Autosomal Recessive Spastic Ataxia - Optic Atrophy - Dysarthria;   Autosomal Recessive Spastic Ataxia;   Autosomal Recessive Metabolic Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to Repeat Expansions That do Not Encode Polyglutamine;   Autosomal Recessive Ataxia, Beauce Type;   Autosomal Recessive Ataxia Due to Ubiquinone Deficiency;   Autosomal Recessive Ataxia Due to PEX10 Deficiency;   Autosomal Recessive Degenerative and Progressive Cerebellar Ataxia;   Autosomal Recessive Congenital Cerebellar Ataxia Due to MGLUR1 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia Due to GRID2 Deficiency;   Autosomal Recessive Congenital Cerebellar Ataxia;   Autosomal Recessive Cerebellar Ataxia-pyramidal Signs-nystagmus-oculomotor Apraxia Syndrome;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to WWOX Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to TUD Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome Due to KIAA0226 Deficiency;   Autosomal Recessive Cerebellar Ataxia-epilepsy-intellectual Disability Syndrome;   Autosomal Recessive Cerebellar Ataxia With Late-onset Spasticity;   Autosomal Recessive Cerebellar Ataxia Due to STUB1 Deficiency;   Autosomal Recessive Cerebellar Ataxia Due to a DNA Repair Defect;   Autosomal Recessive Cerebellar Ataxia - Saccadic Intrusion;   Autosomal Recessive Cerebellar Ataxia - Psychomotor Retardation;   Autosomal Recessive Cerebellar Ataxia - Blindness - Deafness;   Autosomal Recessive Cerebellar Ataxia;   Autosomal Dominant Spinocerebellar Ataxia Due to a Polyglutamine Anomaly;   Autosomal Dominant Spinocerebellar Ataxia Due to a Point Mutation;   Autosomal Dominant Spinocerebellar Ataxia Due to a Channelopathy;   Autosomal Dominant Spastic Ataxia Type 1;   Autosomal Dominant Spastic Ataxia;   Autosomal Dominant Optic Atrophy;   Ataxia-telangiectasia Variant;   Ataxia-telangiectasia;   Autosomal Dominant Cerebellar Ataxia, Deafness and Narcolepsy;   Autosomal Dominant Cerebellar Ataxia Type 4;   Autosomal Dominant Cerebellar Ataxia Type 3;   Autosomal Dominant Cerebellar Ataxia Type 2;   Autosomal Dominant Cerebellar Ataxia Type 1;   Autosomal Dominant Cerebellar Ataxia;   Ataxia-telangiectasia-like Disorder;   Ataxia-intellectual Disability-oculomotor Apraxia-cerebellar Cysts Syndrome;   Ataxia-deafness-intellectual Disability Syndrome;   Ataxia With Vitamin E Deficiency;   Ataxia With Dementia;   Ataxia Neuropathy Spectrum;   Ataxia - Tapetoretinal Degeneration;   Ataxia - Photosensitivity - Short Stature;   Ataxia - Pancytopenia;   Ataxia - Oculomotor Apraxia Type 1;   Ataxia - Hypogonadism - Choroidal Dystrophy;   Ataxia - Other;   Ataxia - Genetic Diagnosis - Unknown;   Acquired Ataxia;   Adult-onset Autosomal Recessive Cerebellar Ataxia;   Alcohol Related Ataxia
    Intervention:  
    Sponsors:   Sanford Health;   National Ataxia Foundation;   International WAGR Syndrome Association;   4p- Support Group;   ML4 Foundation;   Cornelia de Lange Syndrome Foundation;   Stickler Involved People;   Kawasaki Disease Foundation;   Klippel-Feil Syndrome Alliance;   Klippel-Feil Syndrome Freedom;   Hyperacusis Research Limited;   Hypersomnia Foundation;   Kabuki Syndrome Network;   Kleine-Levin Syndrome Foundation;   Leiomyosarcoma Direct Research Foundation;   Marinesco-Sjogren Syndrome Support Group;   Mucolipidosis Type IV Foundation;   People with Narcolepsy 4 People with Narcolepsy (PWN4PWN);   Soft Bones Incorporated
    Recruiting - verified September 2016

  • Conditions:   Anxiety;   Depression
    Interventions:   Behavioral: The PARTNER Intervention;   Other: ICU Usual Care Control
    Sponsor:   University of Pittsburgh
    Recruiting - verified May 2017

  • Condition:   Aphasia
    Interventions:   Device: Activa Dose II Real tDCS;   Device: Activa Dose II Sham tDCS
    Sponsors:   University of South Carolina;   National Institute on Deafness and Other Communication Disorders (NIDCD);   Medical University of South Carolina
    Recruiting - verified May 2017

  • Conditions:   Aphasia;   Stroke
    Intervention:   Behavioral: Script training
    Sponsors:   Rehabilitation Institute of Chicago;   University of Colorado, Boulder
    Recruiting - verified May 2017

  • Condition:   Autism Spectrum Disorders
    Intervention:   Procedure: Transcranial Direct Current Stimulation (tDCS)
    Sponsor:   Johns Hopkins University
    Recruiting - verified March 2017

  • Conditions:   Mucopolysaccharidosis I;   Mucopolysaccharidosis VI;   Adrenoleukodystrophy;   Niemann-Pick Disease;   Metachromatic Leukodystrophy;   Wolman Disease;   Krabbe's Disease;   Gaucher's Disease;   Fucosidosis;   Batten Disease;   Severe Aplastic Anemia;   Diamond-Blackfan Anemia;   Amegakaryocytic Thrombocytopenia;   Myelodysplastic Syndrome;   Acute Myelogenous Leukemia;   Acute Lymphocytic Leukemia
    Intervention:   Drug: Human Placental Derived Stem Cell
    Sponsor:   New York Medical College
    Recruiting - verified July 2016

  • Condition:   Autism Spectrum Disorder
    Intervention:   Behavioral: ISC+PRT Intervention
    Sponsors:   Hugo W. Moser Research Institute at Kennedy Krieger, Inc.;   U.S. Department of Education
    Recruiting - verified January 2017

  • Conditions:   Aphasia;   Stroke
    Intervention:   Device: Magstim SuperRapid
    Sponsors:   University of Alabama at Birmingham;   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified April 2017

  • Conditions:   Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   PLS;   Motor Neuron Disease;   Lou Gehrigs Disease;   Familial Disease;   Amyotrophic Lateral Sclerosis, Sporadic;   Muscular Dystrophy;   Miyoshi Myopathy
    Intervention:  
    Sponsors:   University of Massachusetts, Worcester;   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting - verified August 2016

  • Conditions:   Aphasia;   Stroke;   Cerebrovascular Accident;   Apoplexy;   Cerebral Infarction
    Interventions:   Behavioral: Melodic Intonation Therapy;   Behavioral: Speech-Repetition-Therapy
    Sponsors:   Beth Israel Deaconess Medical Center;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified November 2016

  • Conditions:   Tetraplegia;   Spinal Cord Injuries;   Amyotrophic Lateral Sclerosis;   Brain Stem Infarctions;   Locked in Syndrome;   Muscular Dystrophy
    Intervention:   Device: Placement of the BrainGate2 sensor(s) into the motor-related cortex
    Sponsors:   Leigh R. Hochberg, MD, PhD.;   National Center for Medical Rehabilitation Research (NCMRR);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD);   National Institute on Deafness and Other Communication Disorders (NIDCD);   VA Office of Research and Development;   National Institute of Neurological Disorders and Stroke (NINDS)
    Recruiting - verified September 2016

  • Conditions:   Amyotrophic Lateral Sclerosis (ALS);   Familial Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis With Frontotemporal Dementia;   Lou Gehrig's Disease;   Motor Neuron Disease;   Primary Lateral Sclerosis
    Intervention:   Other: Genetic study of ALS families
    Sponsor:   Northwestern University
    Recruiting - verified January 2017

  • Condition:   Primary Progressive Aphasia
    Intervention:  
    Sponsors:   Northwestern University;   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified January 2017

  • Condition:   Neimann-Pick Disease, Type C
    Intervention:  
    Sponsor:   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
    Recruiting - verified April 4, 2017

  • Condition:   Stuttering
    Intervention:  
    Sponsor:   National Institute on Deafness and Other Communication Disorders (NIDCD)
    Recruiting - verified June 8, 2017